People are loving Blake's musical stylings. When a dog howls along to music, are they complaining because the music hurts their ears, or are they actually trying to sing along?. Most likely, it's the latter—or something like it. According to the American Kennel Club, research shows that canines do actually...
Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now, UC San Francisco researchers have developed a drug that overcomes some of these barriers, marking cancer cells for destruction by the immune system.
Drinking, tanning and smoking are contributing to around 400 “preventable” cases of cancer every day in the UK, new estimates have suggested.The World Cancer Research Fund (WCRF) has estimated that about 155,000 cases of cancer could be prevented every year if people led different lifestyles.It said that some 387,820 people were diagnosed with cancer in 2019/20, the latest figures available.However, people leading unhealthy lifestyles mean this figure is higher than it should be.The charity said that, compared with 2017 data, there was an increase of 8,000 “preventable cases”.It said that about 40% of cancers could be prevented through lifestyle changes...
Researchers have identified trends and risk factors contributing to an increase in the prevalence of early-onset cancers worldwide. Adults under the age of 50 have been diagnosed with cancer at an increasing rate in recent decades. According to a study by Brigham and Women’s Hospital researchers, the incidence of early-onset cancers, or those diagnosed before age 50, has sharply risen globally beginning around 1990. This sharp increase includes cancers of the breast, colon, esophagus, kidney, liver, and pancreas among others.
It was a magical time when animals played sports and yet somehow things were just simpler. Everyone knows that '90s movies just hit different. From sports movies to rom-coms to even horror, there was an undeniable innocence, without being overly simplistic or juvenile. They didn’t have nearly the amount of money going into production as they do today, but somehow managed to transport us to magical places.
VISALIA, Calif. (KSEE/KGPE) – A Visalia resident is meeting with congress members to request an increase in cancer research funding. Cha See, says he has recently seen an increase in cancer in his Lahu community (A Southeast Asian cultural group) and met with Representative Kevin McCarthy to talk about the support needed for an increase […]
Seagen, a specialist in a type of cancer therapy called an antibody drug conjugate (ADC), is expanding its reach with a deal for a preclinical asset that has the potential to stand out in an emerging new class of cancer immunotherapies. According to terms announced Monday, Bothell, Washington-based Seagen is...
The identification of a small molecule drug that can target the brain’s circadian clock proteins may prove effective for treating glioblastoma, the most common cancerous brain tumor in adults, researchers at the Keck School of Medicine of USC announced Monday. Glioblastoma is an aggressive disease. Patients survive an average...
MONDAY, Sept. 26, 2022 (HealthDay News) -- Low-income cancer survivors have increased odds of fair/poor health, and reduced odds of having health insurance coverage, according to a study published online Sept. 6 in JCO Oncology Practice. Steven S. Coughlin, Ph.D., M.P.H., from Augusta University in Georgia, and colleagues examined characteristics,...
YOU MAY ALSO LIKE
(WNDU) - If being told you have cancer wasn’t bad enough, what if the drugs being used to save you almost kill you?. That’s what happened to one young lady in the prime of her life. But she believes being in the right place at the right time saved her life.
Nicholas J. Vogelzang, MD, FASCO, FACP, a cancer pioneer and trailblazing researcher at Comprehensive Cancer Centers, passed away Sept. 20. He was 72. With Comprehensive, Dr. Vogelzang was the practice’s chairman of medical oncology. He preserved and extended the lives of thousands of Southern Nevadans and those who sought his meticulous care from throughout the United States and world. He led and participated in countless clinical trials in genitourinary malignancies, mesothelioma, as well as trials focused on new therapies for patients with metastatic kidney, bladder and prostate cancer. Many of Vogelzang’s research findings and advances have changed cancer care for the better, globally.